Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round.
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round.
DeepMind's mathematical problem-solving agent has shown cheating and anti-cheating behavior in cooperation. Researchers have analyzed this phenomenon and explored new ideas for AI control and governance.